Background SLE is a difficult to treat autoimmune disease due to clinical heterogeneity, unpredictability of disease flares and limited therapeutics. These challenges are worsened in a low-middle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback